Saab has received orders from Latvian Armed Forces and Estonian Armed Forces for deliveries of Carl-Gustaf M4. Deliveries will take place in 2021-2024.

The orders are placed within a framework agreement signed by the Swedish Defence Materiel Administration (FMV) in June 2019, which allows Sweden, Latvia and Estonia to place orders for Carl-Gustaf M4 weapon systems during a ten-year period.

Recipo launched Recipo Material, a purpose-built recycling plant for plastic from electronic waste in Riga, Latvia. In association with their members, Recipo continues to set an example by providing a viable European recycling solution for plastic. As the leading Producer Responsibility Partner for electronics in the Nordic region, Recipo is the first collection scheme in the world to pioneer their own recycling plant.

Designed and engineered focusing on modularity, Bolt’s new specially designed scooter is the most easy-to-repair scooter on the market right now. Thanks to the innovative modular design and engineering, most broken scooters can be restored and put back onto the streets, instead of simply disposing of them.

This recyclability brings two wins:

Airbus and Koniku Inc. have made a significant step forward in the co-development of a solution for aircraft and airport security operations, by extending research activities to include biological hazard detection capabilities, as well as chemical and explosive threats. 

The disruptive biotechnology solution, which was originally focused on the contactless and automated detection, tracking and location of chemicals and explosives on-board aircraft and in airports, is now being adapted, in light of the COVID-19 crisis, to include the identification of biological hazards.

Three leading European Air Forces have deployed single patient isolation pods to rescue covid-19 patients from remote areas. In record time, the EpiShuttle is now in service with The British Royal Air Force, The Royal Norwegian Air Force, the Royal Danish Air Force and the German Air Ambulance DRF.

The use of single patient isolation systems increase the efficiency of our healthcare system during the pandemic outbreak.

• SEAT is collaborating with the healthcare system by making automated ventilators with adapted windscreen wiper motors
• 150 employees from several areas of the company have worked for a week on the definitive model after designing 13 prototypes
• A ventilator is currently undergoing prolonged testing as part of the approval process

SEAT Leon line at the Martorell plant is almost unrecognisable.

The coronavirus (COVID-19) pandemic presents unprecedented health, social and economic challenges for Europe, and has profound implications for the way people live and work across the globe. One of the changes that it is already having is the proportion of people working from home, as governments put in place social distancing and isolation measures. Eurofound research shows which countries already had the highest rates of people doing telework, or ICT-based mobile work, in Europe. 

In the face of the COVID-19 epidemic, the National Health Commission of China has included CT features of COVID-19 as the clinical diagnosis standard for COVID-19 in Hubei Province in its official diagnosis and treatment solution released on February 4, 2020. As one of the decision-making methods for COVID-19 diagnosis and treatment, CT powers fast and effective diagnosis and evaluation. However, due to large numbers of lesions in lungs and rapid changes, multiple rechecks and image reviews are required in a short period of time, significantly increasing the workloads of imaging doctors.

The biopharma company Medicago successfully produced Virus-Like Particles (VLP) of the coronavirus in just 20 days using proprietary plant-based technology Medicago’s platform can produce both vaccine and antibody candidates against COVID-19 disease.

Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that they have successfully produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene.